The medicine for a cancer of lungs is found ...

Scientists from Imperial college of London (Great Britain) have found a medicine which can salvage the patients, suffering the lethal form of a cancer of lungs.

As the cancer extends quickly, the surgical intervention frequently appears powerless. To reduce the size of tumours sometimes it is possible by means of chemotherapy in a combination to radiotheraphy. However tumour growth quickly renews, and it becomes unreceptive to the further treatment.

Accelerates division of cancer cells the factor of growth FGF-2 which also includes the mechanism doing them steady against medicines in cells. Preparation PD173074 does not allow FGF-2 to be attached to tumoral cells and thus stops tumour growth. Medicine PD173074 has been developed in 1998 as an agent, antiblastic blood vessels round malignant tumours.

Tests for mice have shown, that the preparation has destroyed a part of cells small cella cancer at 50 % of experimental rodents and has deprived the remained cells of possibility to resist to standard chemotherapeutic treatment. Now researchers wish to test a new agent for patients with the nonresectable form of oncologic disease.

The cancer of lungs is one of the main oncologic causes of death in the world. The most dangerous the cancer form on which share 20 % of cases of diseases are necessary is considered small cell. Only 3 % of patients with such diagnosis live within five years after illness detection.

Drug Search